Fantino M, Brondel L, Swiergiel A H, Lebec O
Laboratoire de Physiologie, Faculté de Médecine, Université de Bourgogne, Dijon, France.
Life Sci. 1990;46(19):1381-7. doi: 10.1016/0024-3205(90)90338-r.
Cyproheptadine (CH) is a serotonin antagonist that increases food intake and body weight. In order to elucidate its mechanism of action on the control of food intake, hunger ratings, pleasure-displeasure to sweet gustatory stimuli and negative alliesthesia induced by a 50 g glucose load were compared in 14 healthy subjects after they had received a placebo or 16 mg of CH. Cyproheptadine did not affect the hunger rating, nor the affective rating in fasted subjects, but it reduced significantly the negative alimentary alliesthesia induced by the glucose load. It was concluded that CH increases food intake more by reducing satiation than by increasing hunger. This is in line with the anti-serotoninergic properties of CH, and the action of serotonin on the control of food intake.
赛庚啶(CH)是一种血清素拮抗剂,可增加食物摄入量和体重。为了阐明其对食物摄入控制的作用机制,在14名健康受试者接受安慰剂或16毫克CH后,比较了他们的饥饿评分、对甜味味觉刺激的愉悦-不愉悦感以及50克葡萄糖负荷引起的负性变应性。赛庚啶不影响饥饿评分,也不影响禁食受试者的情感评分,但它显著降低了葡萄糖负荷引起的负性食物变应性。得出的结论是,CH增加食物摄入量更多是通过降低饱腹感而不是增加饥饿感。这与CH的抗血清素能特性以及血清素对食物摄入控制的作用一致。